Armando Valdes, the owner and operator of a medical clinic in Miami, allegedly submitted false claims to the insurance companies for infusions of infliximab, known by the brand name Remicade, which were medically unnecessary and not provided to patients as billed. The drug is used to treat several diseases, including Crohn’s disease and ulcerative colitis.
Mr. Valdes used nearly $8 million in proceeds from the alleged scheme to buy real estate and luxury vehicles, the indictment alleges.
Mr. Valdes is charged with 10 counts of healthcare fraud and faces up to 100 years in prison if convicted, according to the Justice Department.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
